Vitamin C Derivative Sap Sodium L-Ascorbyl-2-Phosphate

Name: Vitamin C Derivative Sap Sodium L-Ascorbyl-2-Phosphate
Brand: Xi'an LY Health Technology Co., Ltd
SKU: 1991651491

Shaanxi, ChinaXi'an LY Health Technology Co., Ltd

US$0.15-0.35

100 gram

Product profile

Customization

Available

CAS No.

66170-10-3

Formula

C6h9o9p.3na

Model NO.

LYJK-Sodium L-Ascorbyl-2-Phosphate

EINECS

425-180-1

Type

Synthesis Material Intermediates

Appearance

off White Powder

Quality

Technical

Colour

White

Other Names

Sodium Ascorbyl Phosphate

Product Name

Sodium L-Ascorbyl-2 Phosphate

Purity

≥95%, up to 99%

Lyjk-Sodium L-Ascorbyl-2

Modelnumber Phosphate

Single Package Size

35X25X25.Cm

Grade

Cosmetic Grade;Food Grade

MOQ

100g

Packing

1kg/Bag:25kg/Drum

Einecs No.

207-922-4

Single Gross Weight

1.500kg

Test Method

HPLC

Mf

C6h6na309p

Free Sample

Avalibale

Delivery

1-3 Days Usually

Application

Skin Whitening

Transport Package

as Your Requestion

Specification

Cosmetics Grade & Food Grade

Trademark

LYHealth

Origin

Shaanxi, China

Company profile

High Repeat Buyers ChoiceFast Delivery100% Finished Products InspectionQuality Assurance

Xi'an LY Health Technology Co., Ltd

Shaanxi, China

Business Type: Manufacturer/Factory CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 5 Years CertifiedNearest Port: Beijing Port; Qingdao Port; Shanghai PortAverage Response Time: ≤2.50h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an LY Health Technology Co., Ltd. is a China-based trading company established in 2021 with six employees. Its stated product scope includes plant extracts, pharmaceutical intermediates, health supplements, cosmetic raw materials, and veterinary raw materials. The supplier reports that 90% of total sales are exports and that it has exported for five years. It offers several forms of customization, but its R&D resources are limited: one engineer, no patents, no new products in the past year, no SDK, and no available design documentation for audit. The supplier does not provide ODM services or OEM services for popular brands. Service-management controls are weak or undocumented, and no overseas warehouse, showroom, agent or branch, or offline trade-show experience is reported. The provided information does not establish certifications, production facilities, customer cases, or verified financial strength.

Supplier typeThe supplier is identified as a limited company and specifically classified as a trading company, with six employees and a product portfolio covering plant extracts, pharmaceutical intermediates, health supplements, cosmetic raw materials, and veterinary raw materials. This indicates an intermediary or trading-oriented business model rather than confirmed in-house manufacturing.

After-Sales capabilityThe supplier has not provided written procedures or records for handling customer complaints, corrective and preventive actions, or effective supplier-service assessment. It also reports no overseas warehouse, showroom, overseas agent or branch, and no offline trade-show participation, indicating limited documented after-sales and overseas support infrastructure.

R&D capabilityInnovation evidence is weak: the supplier reports no new products in the past year, no available SDK, one R&D engineer, zero patents, and no design input, output, review, verification, or validation documentation available for audit. These stated limitations indicate a deficiency in demonstrated R&D and innovation capability.

Customization capabilityThe supplier explicitly reports customization from designs, samples, full customization, minor customization, and flexible customization, with an R&D engineer responsible for providing samples according to customer requirements. However, the absence of R&D documentation and the single-engineer team limits verification of the depth and scalability of this capability.